preliminarily concluded<\/a> that\u00a0reduced pulmonary function, increased asthma prevalence, reduced asthma control, allergy-related conditions, male and female reproductive toxicity, and developmental effects are associated with chronic inhalation exposure to formaldehyde. <\/p>\n\n\n\nWorkers currently employed in 41 occupational scenarios, including processing as a reactant, incorporation into an article, and incorporation into a mixture, are exposed at levels corresponding to what the agency determined is \u201cunreasonable risk\u201d of these health effects. The 8-hour occupational exposure limit would have to be set at 0.0011 ppm to avoid unreasonable risk for workers, according to EPA\u2019s draft assessment; the current ACGIH recommended limit is 0.1 ppm. <\/p>\n\n\n\n
Following peer review of the draft and consideration of public comments, and issuance of the final risk evaluation, EPA will proceed with development of a risk management standard that may ban or limit certain uses of formaldehyde or require adoption of controls to prevent workplace exposures above the levels associated with unreasonable risk. <\/p>\n\n\n\n
Contact John Schweitzer<\/a> for more information.<\/p>\n","protected":false},"excerpt":{"rendered":"EPA Finds Workplace Exposure to Formaldehyde Presents an Unreasonable Risk to Human Health EPA has\u00a0preliminarily concluded that\u00a0reduced pulmonary function, increased asthma prevalence, reduced asthma control, allergy-related conditions, male and female […]<\/p>\n","protected":false},"author":58,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[42],"tags":[],"acf":[],"yoast_head":"\n
Regulatory Updates - ACMA Insider - March 21, 2024 - American Composites Manufacturers Association<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n